Casdin Capital’s Curis CRIS Stock Holding History

Casdin Capital’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-43	Closed	-$161K	–	27
2017 Q2	$161K	Sell	43 -72	-63%	-$301K	0.06%	35
2017 Q1	$639K	Buy	+115	New	+$639K	0.38%	29

Other funds holding CRIS

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Casdin Capital's CRIS Position: Q3 2017 in Review

Casdin Capital sold out of Curis (CRIS) in Q3 2017, closing a stake of 43 shares — an estimated $161K sold.

Casdin Capital first reported a position in CRIS in Q1 2017 and held it in 2 quarters. The position peaked at $639K in Q1 2017. 82 funds tracked by Wall St. Rank hold CRIS as of Q3 2017.

Casdin Capital reported no remaining Curis position as of Q3 2017 after selling out during the quarter.
Casdin Capital sold 43 Curis shares in Q3 2017, an estimated $161K.
Casdin Capital first reported a position in Curis in Q1 2017 and held it in 2 quarters.
Casdin Capital's Curis position peaked at $639K in Q1 2017.
82 funds tracked by Wall St. Rank held Curis as of Q3 2017.

Based on Casdin Capital's 13F filing for Q3 2017, filed 14 Nov 2017.